Biotage AB (publ) publishes its 2014 Annual Report and Corporate Governance Report and new Financial Goals
Biotage’s 2014 Annual Report and Corporate Governance Report are as of today available at: www.biotage.com
Biotage has previously had three financial goals that form a basis for the strategic plan – one goal for organic growth, one gross margin goal and one EBIT margin goal. The gross margin and EBIT margin goals are to some extent overlapping. Hence, the board has resolved to refine the financial goals with one goal for organic growth and one goal for EBIT margin. There will be a continued focus on the gross margin also going forward as part of the efforts to reach the EBIT margin goal.
From now and on Biotage have two financial goals in its business, an organic growth goal of 8 percent and an EBIT-goal of 10 percent. The goals are formulated as an average for the three-year period 2013-2015.
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, firstname.lastname@example.org
Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08.30 on March 26, 2015.
Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 490 MSEK in 2014. Biotage is listed on the NASDAQ OMX Stockholm stock exchange. Website: www.biotage.com